Did CEOs and officers buy or sell their own stock?
Open-market trades by the people who know the company best, with their own money.
Last 7 days: the stocks insiders bought and sold most
Stocks Koreans hold most · disclosed Last 7 days · open-market trades only
Bought most
Sold most
Whalegun
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Stephen L. SabbaDirector | Ligand PharmaceuticalsLGND | Open-market sale | 06/16 | 06/18 | 2,145 sh | $254.00 | $544,830 | −6.0% |
Ligand PharmaceuticalsLGND | Open-market sale | 06/12 | 06/15 | 6,461 sh2 trades | $255.58avg. | $1,651,322.88 | −56.5% | |
Ligand PharmaceuticalsLGND | Open-market sale | 06/10–06/11 | 06/12 | 5,000 sh2 trades | $250.00avg. | $1,250,000 | −4.6% | |
Ligand PharmaceuticalsLGND | Open-market sale | 06/10 | 06/12 | 4,591 sh4 trades | $250.88avg. | $1,151,785.57 | −14.5% | |
Ligand PharmaceuticalsLGND | Open-market sale | 06/01 | 06/02 | 5,000 sh7 trades | $227.06avg. | $1,135,323.29 | −10.8% | |
Ligand PharmaceuticalsLGND | Open-market sale | 05/01–05/13 | 05/14 | 2,501 sh7 trades | $225.14avg. | $563,080.81 | −5.6% | |
Ligand PharmaceuticalsLGND | Open-market sale | 05/01 | 05/04 | 5,000 sh7 trades | $231.31avg. | $1,156,552.08 | −10.8% | |
Ligand PharmaceuticalsLGND | Open-market sale | 04/01 | 04/02 | 467 sh5 trades | $202.22avg. | $94,438.87 | −1.1% | |
Ligand PharmaceuticalsLGND | Open-market sale | 04/01 | 04/02 | 5,000 sh6 trades | $201.24avg. | $1,006,217.52 | −10.8% | |
John L. LamattinaDirector | Ligand PharmaceuticalsLGND | Open-market sale | 03/06 | 03/31 | 2,161 sh | $200.76 | $433,842.36 | −6.6% |
Stephen L. SabbaDirector | Ligand PharmaceuticalsLGND | Open-market sale | 03/23 | 03/25 | 1,000 sh | $207.87 | $207,870 | −3.0% |
Ligand PharmaceuticalsLGND | Open-market sale | 03/11 | 03/13 | 3,057 sh | $225.00 | $687,825 | −12.7% | |
Ligand PharmaceuticalsLGND | Open-market sale | 03/04 | 03/06 | 13,423 sh11 trades | $205.83avg. | $2,762,844.76 | −38.3% | |
Ligand PharmaceuticalsLGND | Open-market sale | 03/04 | 03/06 | 5,000 sh11 trades | $206.35avg. | $1,031,774.16 | −11.9% | |
Stephen L. SabbaDirector | Ligand PharmaceuticalsLGND | Open-market sale | 03/03 | 03/05 | 2,034 sh | $201.50 | $409,851 | −5.7% |
Ligand PharmaceuticalsLGND | Open-market sale | 03/02 | 03/04 | 467 sh6 trades | $200.50avg. | $93,632.63 | −1.1% | |
Ligand PharmaceuticalsLGND | Open-market sale | 02/02 | 02/04 | 467 sh5 trades | $195.91avg. | $91,488.97 | −1.1% | |
Ligand PharmaceuticalsLGND | Open-market sale | 01/02 | 01/06 | 467 sh5 trades | $189.58avg. | $88,532.05 | −1.1% | |
Ligand PharmaceuticalsLGND | Open-market sale | 25/12/12 | 25/12/16 | 1,804 sh | $188.31 | $339,711.24 | −6.4% | |
Ligand PharmaceuticalsLGND | Open-market sale | 25/12/01 | 25/12/03 | 467 sh7 trades | $195.84avg. | $91,458.06 | −1.0% |